Related Experiment Videos

The Heterogeneity of Long-Term Cardiopulmonary Outcomes in Children Born Preterm May Benefit from Pulmonary

Meaghan C Rousset1, Rachel T Sullivan2, Anna M Brown1

  • 1Division of Pulmonary Medicine, Department of Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA.

Pulmonary Circulation
|August 8, 2026
PubMed

Insights

Preterm birth survivors with bronchopulmonary dysplasia (BPD) may develop pulmonary hypertension (PH). Long-term monitoring reveals varied outcomes and potential cardiopulmonary complications requiring specialized care.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Cardiology

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease common in preterm infants.
  • Infants with BPD face an increased risk of pulmonary vascular disease (PVD), including pulmonary hypertension (PH).
  • Adult survivors of prematurity with BPD represent a growing population with potential long-term health issues.

Purpose of the Study:

  • To present three cases of preterm patients with BPD-associated PH (BPD-PH) monitored from childhood to young adulthood.
  • To highlight the variability in management strategies and late outcomes for individuals with BPD-PH.
  • To underscore the need for continued research into the long-term management of cardiopulmonary disease in this cohort.

Main Methods:

  • Case series of three preterm patients with a history of BPD-PH.
  • Monitoring of pulmonary hypertension (PH) using transthoracic echocardiogram (TTE) throughout childhood and young adulthood.
  • Review of management strategies and long-term cardiopulmonary outcomes.

Main Results:

  • All three patients showed early resolution of PH on transthoracic echocardiogram (TTE).
  • One patient discontinued long-term follow-up.
  • Two patients experienced late cardiopulmonary complications necessitating PH-specialty management.

Conclusions:

  • The cardiopulmonary sequelae of prematurity, particularly BPD-PH, persist beyond early childhood.
  • Long-term management and monitoring are crucial for preterm survivors with BPD-PH to mitigate complications.
  • Further research is needed to optimize long-term care strategies for this growing population.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...